Patent details

EP4027815 Title: COMPOSITIONS COMPRISING CYTISINE IN THE TREATMENT AND/OR PREVENTION OF ADDICTION IN SUBJECTS IN NEED THEREOF

Basic Information

Publication number:
EP4027815
PCT Application Number:
US2020046308
Type:
European Patent Granted for LU
Legal Status:
In force
Application number:
EP208628438
PCT Publication Number:
WO2021050203
First applicant's nationality:
Translation Language:
EPO Publication Language:
English
English Title of Invention:
COMPOSITIONS COMPRISING CYTISINE IN THE TREATMENT AND/OR PREVENTION OF ADDICTION IN SUBJECTS IN NEED THEREOF
French Title of Invention:
COMPOSITIONS COMPRENANT DE LA CYTISINE DANS LE TRAITEMENT ET/OU LA PRÉVENTION DE L'ADDICTION CHEZ DES SUJETS EN AYANT BESOIN
German Title of Invention:
ZUSAMMENSETZUNGEN MIT CYTISIN BEI DER BEHANDLUNG UND/ODER VORBEUGUNG EINER SUCHT BEI PROBANDEN, DIE DIESE BENÖTIGEN
SPC Number:

Dates

Filing date:
14/08/2020
Grant date:
15/04/2026
EP Publication Date:
20/07/2022
PCT Publication Date:
18/03/2021
Claims Translation Received Date:
Translations Received Date (B1 EP Publication):
Translations Received Date (B2 EP Publication):
Translations Received Date (B3 EP Publication):
Publication date:
15/04/2026
EP B1 Publication Date:
15/04/2026
EP B2 Publication Date:
EP B3 Publication Date:
Lapsed date:
Expiration date:
14/08/2040
Renunciation date:
Revocation date:
Annulment date:

Owner

From:
08/04/2026
 
 

Name:
Achieve Life Sciences, Inc.
Address:
520 Pike Street, Suite 2250, Seattle, WA 98101, United States (US)

Inventor

1

Name:
JACOBS, Cindy, A.
Address:
United States (US)

2

Name:
CLARKE, Anthony
Address:
United Kingdom (GB)

3

Name:
CAIN, Daniel, F.
Address:
United States (US)

Priority

1

Priority Number:
201962899637 P
Priority Date:
12/09/2019
Priority Country:
United States (US)

2

Priority Number:
202062988890 P
Priority Date:
12/03/2020
Priority Country:
United States (US)

Classification

IPC classification:
A61K 31/439; A61K 31/465; A24B 15/16; A61K 9/00; A61P 25/34;

Publication

European Patent Bulletin

Issue number:
202616
Publication date:
15/04/2026
Description:
Grant (B1)

Annual Fees

Annual Fee Due Date:
31/08/2026
Annual Fee Number:
7
Annual Fee Amount:
82 Euro
Expected Payer:
Last Annual Fee Payment Date:
Last Annual Fee Paid Number:
Payer:
Filing date Document type Number of pages